Publication: Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar
Issued Date
2021-12-01
Resource Type
ISSN
14712458
Other identifier(s)
2-s2.0-85105169274
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
BMC Public Health. Vol.21, No.1 (2021)
Suggested Citation
Shwe Sin Kyaw, Gilles Delmas, Tom L. Drake, Olivier Celhay, Wirichada Pan-ngum, Sasithon Pukrittayakamee, Yoel Lubell, Ricardo J. Aguas, Richard James Maude, Lisa J. White, Francois Nosten Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar. BMC Public Health. Vol.21, No.1 (2021). doi:10.1186/s12889-021-10842-5 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/77594
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar
Abstract
Background: Mass drug administration (MDA) has received growing interest to accelerate the elimination of multi-drug resistant malaria in the Greater Mekong Subregion. Targeted MDA, sometimes referred to as focal MDA, is the practice of delivering MDA to high incidence subpopulations only, rather than the entire population. The potential effectiveness of delivering targeted MDA was demonstrated in a recent intervention in Kayin State, Myanmar. Policymakers and funders need to know what resources are required if MDA, targeted or otherwise, is to be included in elimination packages beyond existing malaria interventions. This study aims to estimate the programmatic cost and the unit cost of targeted MDA in Kayin State, Myanmar. Methods: We used financial data from a malaria elimination initiative, conducted in Kayin State, to estimate the programmatic costs of the targeted MDA component using a micro-costing approach. Three activities (community engagement, identification of villages for targeted MDA, and conducting mass treatment in target villages) were evaluated. We then estimated the programmatic costs of implementing targeted MDA to support P. falciparum malaria elimination in Kayin State. A costing tool was developed to aid future analyses. Results: The cost of delivering targeted MDA within an integrated malaria elimination initiative in eastern Kayin State was approximately US$ 910,000. The cost per person reached, distributed among those in targeted and non-targeted villages, for the MDA component was US$ 2.5. Conclusion: This cost analysis can assist policymakers in determining the resources required to clear malaria parasite reservoirs. The analysis demonstrated the value of using financial data from research activities to predict programmatic implementation costs of targeting MDA to different numbers of target villages.